Th-227-Epratuzumab (Th-227-BAY1862864)
227Th-Epratuzumab (227Th-BAY1862864 is a CD-22 thorium conjugate targeting relapsed or [...]
Ac-225-PSMA-617
225Ac-PSMA-617 is the next generation of prostate cancer treatment following [...]
Ac-225-Lintuzumab (Ac-225 Actimab-A™)
225Ac-Lintuzumab (225Ac-Actimab-A™, 225Ac-DOTA-huM195, 225Ac-DOTA-Lintuzumab) is the new name of the [...]
Ac-225-FPI-1434
225Ac-FPI-1434 (225Ac-FPX-01) is an alpha labeled antibody under development for [...]
Bi-213-Lintuzumab (Bi-213 Bismab-A™)
213Bi-Lintuzumab (213Bi-Bismab-A™, 213Bi-CHX-A’’-DTPA-huM195) is an anti-CD33 humanized antibody huM195 labeled [...]
Pb-212-DOTAMTATE
212Pb-DOTAMTATE (212Pb-AlphaMedix™) is a somatostatin analogue labeled with Lead-212 and [...]
At-211-MX35-F(ab’)-2
211At-MX35-F(ab’)2 is a radiolabeled antibody fragment developed and characterized at [...]
At-211-81C6 mAb (Neuradiab)
211At-81C6-mAb (anti tenascin, human/mouse chimeric antibody) is a radiotherapeutic based [...]
Re-188-P2045 (Tozaride)
188Re-P2045 (BAY86-5284, Tozaride) is a 11-amino acid proprietary somatostatin [...]
Re-188-Rhenium Lipiodol
188Re-HDD/Lipiodol is a generic therapeutic in form of a mixture [...]